NVO Tshuag dhia tom qab Novo Nordisk nthuav cov ntshav qab zib ua rau Pfizer, Eli Lilly

Food and Drug Administration nthuav daim ntawv lo rau Novo Nordisk's (NVO) Cov tshuaj noj ntshav qab zib qhov ncauj, ua rau NVO cov khoom lag luam dhia rau hnub Friday.

X

Tam sim no, cov neeg mob uas muaj ntshav qab zib hom 2 tuaj yeem noj Rybelsus yam tsis tas yuav ua ntej sim lwm txoj kev kho mob, Novo Nordisk tau hais hauv xov xwm tshaj tawm. Thaum FDA thawj zaug pom zoo Rybelsus hauv 2019, nws tsis raug tso cai ua thawj zaug kho mob ntshav qab zib hom 2.

Qhov kev txav mus ntxiv nthuav dav Novo Nordisk cov thawj coj hauv chav kawm tshuaj no. Rybelsus yog tib cov tshuaj uas txhawb nqa cov tshuaj hu ua GLP-1. Pfizer (PFE) thiab Eli Lilly (LLY) vam tias yuav tso lawv cov tshuaj ntshav qab zib siv tib lub tswv yim. Lwm cov tshuaj tsom rau GLP-1 yog txhaj.

Nyob rau Tshuag lag luam hnub no, NVO Tshuag popped 2% mus kaw ntawm 136.32. Pfizer thiab Lilly shares kuj tau nce ib feem.

NVO Tshuag: 'Pivotal' Diabetes Med

Doug Langa, Novo tus lwm thawj tswj hwm ntawm North America kev ua haujlwm, hu ua Rybelsus "ib feem tseem ceeb ntawm peb cov ntaub ntawv" hauv tsab ntawv sau tseg.

Thaum lub Cuaj Hlis lub quarter, Rybelsus tau tsim txog $ 437 lab hauv kev muag khoom. Qhov ntawd suav txog li 13% ntawm tag nrho Novo's GLP-1-kev kho mob tsom. Novo kuj muag Ozempic thiab Victoza, GLP-1 txhaj tshuaj. NVO cov khoom lag luam feem ntau tau nce siab txij li nws daim ntawv tshaj tawm peb lub hlis twg.

Rybelsus nkoos GLP-1, ib yam tshuaj uas ua rau lub plab zom mov qeeb, txwv tsis pub lub siab ua suab thaj ntau dhau thiab pab txiav txiav tsim cov tshuaj insulin ntau dua. Cov tshuaj no feem ntau pom muaj nyob rau hauv cov neeg mob uas muaj ntshav qab zib hom 2.

"Hauv Asmeskas, ntau pua txhiab tus neeg mob ntshav qab zib hom 2 tau muab tshuaj no ua ib feem ntawm lawv txoj kev kho mob ntshav qab zib hom 2 los pab txo lawv cov A1C," Langa tau hais. A1C yog ib qho kev kuaj ntshav uas ntsuas qhov nruab nrab cov ntshav qab zib ntau tshaj peb lub hlis. Nws yog ib qho qhia txog kev mob ntshav qab zib mellitus.

Shares muaj zog Ntsuam Xyuas Lub Zog Muaj Zog ntawm 92 tawm ntawm qhov zoo tshaj plaws-muaj peev xwm 99. Qhov no tso NVO cov khoom lag luam nyob rau saum 8% ntawm tag nrho cov khoom lag luam thaum nws los txog rau 12-lub hlis kev ua tau zoo, raws li IB Digital.

Thaum lub Kaum Ib Hlis lig, Novo shares tau tawg tawm ntawm kev sib koom ua ke nrog a muas point thaum 122.26, MarketSmith.com qhia. Lawv twb tua tawm ntawm ib tug yuav tsam, tab sis NVO Tshuag tseem qis dua a profit-taking tsam.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Yuav Ua Li Cas IBD Tshuag Ntawm Lub Hnub Insulet Ua Ib 'Moat' Kom Tawm Ntawm Cov Rivals

Intuitive Surgical Dives Raws li Cov Txheej Txheem Tshiab Flop; InMode Kuj Skids

Tau Txais Sijhawm Yuav & Muag Alerts Nrog IBD Thawj Coj

Pom Qhov Kev Lag Luam Zoo Tshaj Plaws Sij Hawm Zoo Nrog IBD Cov Thawj Coj Ua Haujlwm Ntev

Zoo Tshaj Lij Tshaj Lij Yuav Zoo Tshaj Plaws Yuav Thiab Saib: Saib Xyuas Cov Khoom Qhia Tshiab Rau IBD Cov Ntawv Sau Npe